JBJürgen Brosius

Jürgen Brosius

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jürgen Brosius has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Deng

    Department of Respiratory and Critical Care Medicine, Center for High Altitude Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China

    6 shared publications
  • Chang Zhang

    Department of High Altitude Medicine, Center for High Altitude Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, PR China

    3 shared publications
  • Huaping Zheng

    Department of High Altitude Medicine Center For High Altitude Medicine College of Life Sciences National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu Sichuan People's Republic of China

    3 shared publications
  • Qian Sun

    Department of High Altitude Medicine, Center for High Altitude Medicine, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

    3 shared publications
  • Jian Liu

    Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China

    2 shared publications
  • Jingqiu Cheng

    Department of Respiratory and Critical Care Medicine, Center for High Altitude Medicine, Institutes for Systems Genetics, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications

Latest Publications

  • Constitutively active glucagon receptor (GCGR) physiologically regulates body temperature in lizards

    by Songsong Liu, Qingqing Ren, Shanshan Lai, Xiangying Xiang, Yongjie Huang, Qingqing Wang, Qiujinman Mao, Xiaofei Yan, Ao Dai, Najeeb Ullah, et al.

    Endotherms use complex internal mechanisms to maintain a steady body temperature, whereas ectotherms rely on environmental factors and behaviors for thermoregulation. Certain ectothermic animals, like some lizards, can also physiologically regulate their body temperature to some extent, with interspecies variations in thermoregulatory capacity under low-temperature conditions. However, the molecular mechanisms underlying this physiological regulation have remained unclear since its discovery about 80 years ago. Here, we reveal that the hepatic expression of constitutively active glucagon receptor (GCGR) in lizards, particularly in iguana, correlated with their thermoregulatory capacity when kept at low temperatures. When Pogona vitticeps and Phrynocephalus vlangalii with thermoregulatory capacity were treated with short hairpin RNA– GCGR or GCGR antagonist, their body temperatures dropped, and the expression of genes related to energy metabolism and respiratory metabolic rate was down-regulated. In contrast, Eremias argus , lacking thermoregulatory ability, revealed low hepatic GCGR expression. Overexpression of P. vitticeps GCGR (pv GCGR ) in the liver of E. argus increased body temperature and enhanced energy metabolism. Furthermore, in mice with reduced thermoregulatory ability by chlorpromazine administration, overexpression of constitutively active GCGR ligand-independently increased body temperature under cold conditions. In conclusion, constitutively active GCGR drives the physiological thermoregulation in lizards, and our study offered previously unidentified insights into expression regulation of constitutively active GPCR into physiological adaptations responding to environmental changes.

  • Open Access

    A novel long-galanin peptide from non-mammalian vertebrates mitigates the inflammatory response in IBD models via the biased GALR2/β-arrestin2 pathway

    by Shanshan Lai, Xianglin Kong, Jingwen Xue, Kaili Ma, Amanullah Amanullah, Yuwei Chen, Na Yang, Ting Zhang, Kun Zheng, Tao Zeng, et al.

    Galanin, a neuropeptide, regulates immune and inflammatory responses via GALR1-3. GALRs have emerged as potential therapeutic targets for inflammatory bowel disease (IBD), yet their mechanistic roles remain unclear. Based on evolutionary analysis, we identified a long galanin isoform (GAL53), generated by alternative splicing in non-mammalian vertebrates. Here we show that the chicken ortholog cGAL53 is robustly expressed in colonic tissue but downregulated upon dextran sulfate sodium (DSS)-induced colitis. Administration of cGAL53 alleviates colitis-associated weight loss, colon shortening, bleeding, and inflammation in both chickens and mice. These effects are abolished in Galr2-deficient mice, highlighting receptor dependency. Moreover, epithelial cell-specific Arrb2 and Gnaq knockout models demonstrate that cGAL53 protects the gut barrier and reduces inflammation by activating β-arrestin2-biased GALR2 signaling. Our findings reveal a naturally occurring long galanin peptide with potent anti-inflammatory activity and propose evolutionary medicine-guided biased GALR2 agonism as a therapeutic strategy for IBD.


  • Open Access

    Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatment

    by Chang Zhang, Xue Wang, Chenxi Feng, Huaping Zheng, Song Leng, Yiheng Jiang, Qian Sun, Xiaoou Li, Ting Zhang, Jiacheng Zhang, et al.

    Human obesity is the fifth leading cause of global mortality. Fat mass loss and maintenance are central challenges for obesity management. In contrast, birds exhibit modest weight gain and limited fat accumulation due to rapid fat utilization as flight fuel. The physiology of this adaptation remained a mystery for a century. Here we show that cross-species single-nucleus RNA-sequencing analysis revealed high GCGR expression levels in avian adipocytes, while minimal in the adipose tissue of other vertebrates. Avian GCGR employs a unique rapid fat utilization mechanism for retaining a light body. Avian GCGR or other constitutively active GCGR variants (human GCGRH339R) expressed in white adipose tissue of male mice with obesity effectively promoted fat mobilization and sustained body weight loss, with decreased food intake partially contributing to the observed weight reduction. We suggest that avian GCGR plays this crucial role for fat utilization and may offer therapeutic potential for human obesity.


  • Open Access

    Constitutively active glucagon receptor drives high blood glucose in birds

    by Chang Zhang, Xiangying Xiang, Jian Liu, Yongjie Huang, Jingwen Xue, Qian Sun, Song Leng, Shaobo Liu, Xuefei He, Peng Hu, et al.

    As the body’s primary source of energy, the maintenance of blood glucose is indispensable for overall health and metabolic homeostasis. It is predominantly regulated by the glucagon receptor family which is highly conserved in vertebrates1–4. Compared to other vertebrates, avian blood glucose levels are relatively high5,6, yet its regulatory mechanisms have remained obscure for more than a century. We show that high hepatic expression of the avian glucagon receptor (GCGR) in association with constitutively active Gs signaling was dependent upon the interaction of different domains. In vivo experiments focusing on the regulation of constitutively active GCGR expression in hepatic cells led to correspondingly high blood glucose, rapid hepatic lipid utilization and high metabolic rates via downstream signaling pathway activation in fish, reptiles, birds, and mammals. Furthermore, we identified a point mutation in chicken at the proximal gene region that resulted in GCGR mRNA reduction and weight increase. Overexpressing a natural human GCGR mutation (hsGCGRH339R) with modest constitutive activity in mice, demonstrated that high level expression of this variant augmented high blood glucose, while reducing body weight. The combination of high expression and constitutive activity of the glucagon receptor may have contributed to the evolution of flight in the ancestors of birds.


  • Top Cited Papers
    Open Access

    S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity

    by Huaping Zheng, Jingjing Yu, Luhua Gao, Kexin Wang, Zheng Xu, Zhen Zeng, Kun Zheng, Xiaoju Tang, Xiaowen Tian, Qing Zhao, et al.

    G protein-coupled sphingosine-1-phosphate receptor 1 (S1PR1), a drug target for inflammatory bowel disease (IBD), enables immune cells to egress from lymph nodes, but the treatment increases the risk of immunosuppression. The functional signaling pathway triggered by S1PR1 activation in endothelial cells and its therapeutic application remains unclear. Here, we showed that S1PR1 is highly expressed in endothelial cells of IBD patients and positively correlated with endothelial markers. Gi-biased agonist-SAR247799 activated S1PR1 and reversed pathology in male mouse and organoid IBD models by protecting the integrity of the endothelial barrier without affecting immune cell egress. Cryo-electron microscopy structure of S1PR1-Gi signaling complex bound to SAR247799 with a resolution of 3.47 Å revealed the recognition mode for the biased ligand. With the efficacy of SAR247799 in treating other endothelial dysfunction-associated inflammatory diseases, our study offers mechanistic insights into the Gi-biased S1PR1 agonist and represents a strategy for endothelial dysfunction-associated disease treatment.


  • Open Access

    Exploring Alu -Driven DNA Transductions in the Primate Genomes

    by Reza Halabian, Jessica M. Storer, Savannah J. Hoyt, Gabrielle A. Hartley, Jürgen Brosius, Rachel J. O’neill, Wojciech Makałowski

    Long terminal repeats (LTRs) and non-LTRs retrotransposons, aka retroelements, collectively occupy a substantial part of the human genome. Certain non-LTR retroelements, such as L1 and SVA, have the potential for DNA transduction, which involves the concurrent mobilization of flanking non-transposon DNA during retrotransposition. These events can be detected by computational approaches. Despite being the most abundant short interspersed sequences (SINEs) that are still active within the genomes of humans and other primates, the transduction rate caused by Alu sequences remains unexplored. Therefore, we conducted an analysis to address this research gap and utilized an in-house program to probe for the presence of Alu -related transductions in the human genome. We analyzed 118,489 full-length Alu Y subfamilies annotated within the first complete human reference genome, T2T-CHM13. For comparative insights, we extended our exploration to two non-human primate genomes, the chimpanzee and the rhesus monkey. After manual curation, our findings did not confirm any Alu -mediated transductions, whose source genes are, unlike L1 or SVA, transcribed by RNA polymerase III, implying that they are infrequent or possibly absent not only in the human but also in chimpanzee and rhesus monkey genomes. Although we identified loci in which the 3’ Target Site Duplication (TSD) was located distantly from the retrotransposed Alu Ys, a transduction hallmark, our study could not find further support for such events. The observation of these instances can be explained by the incorporation of other nucleotides into the poly(A) tails in conjunction with polymerase slippage.

  • Open Access

    GPR15–C10ORF99 functional pairing initiates colonic Treg homing in amniotes

    by Jingjing Song, Huaping Zheng, Jingwen Xue, Jian Liu, Qian Sun, Wei Yang, Fang Liu, Xiangyin Xiang, Kai He, Younan Chen, et al.

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.